stars 1 stars 2 stars 3

Biomedcode is a CRO with extensive expertise in efficacy evaluation studies using standardized preclinical platforms of inflammatory and fibroproliferative diseases as well as cancer. Biomedcode combines scientific consultation and custom-tailored solutions towards optimizing the validation procedure of novel human therapeutics including biologics, biosimilars, biobetters and small molecules. Offered services include animal disease model development, in-vivo and ex-vivo preclinical drug evaluation, PK/PD analysis, standardized sample collection and analysis, histopathology, immunohistochemistry as well as molecular, cellular and immunological assays and pharmacogenomics. Since 2006, Biomedcode has provided its services to more than 126 pharmaceutical and biotech companies in Europe, the USA and Asia. Learn more about Biomedcode SA at www.biomedcode.com

View Top Employees from Biomedcode Hellas S.A. - Priming Drugs for success

Biomedcode Hellas S.A. - Priming Drugs for success Questions

The Biomedcode Hellas S.A. - Priming Drugs for success annual revenue was $5 million in 2024.

10 people are employed at Biomedcode Hellas S.A. - Priming Drugs for success.

Biomedcode Hellas S.A. - Priming Drugs for success is based in Vari, Attica.

The NAICS codes for Biomedcode Hellas S.A. - Priming Drugs for success are [5417, 541, 54, 541714, 54171].

The SIC codes for Biomedcode Hellas S.A. - Priming Drugs for success are [87, 873].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users